SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-21-052176
Filing Date
2021-10-12
Accepted
2021-10-12 06:09:40
Documents
7
Period of Report
2021-10-11

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea148653-6k_alteritythera.htm 6-K 11950
2 NOTICE OF ANNUAL GENERAL MEETING/PROXY FORM ea148653ex99-1_alteritythera.htm EX-99.1 202550
3 GRAPHIC ex99-1_001.jpg GRAPHIC 6100
4 GRAPHIC ex99-1_002.jpg GRAPHIC 117205
5 GRAPHIC ex99-1_003.jpg GRAPHIC 123166
6 GRAPHIC ex99-1_004.jpg GRAPHIC 1747
7 GRAPHIC ex99-1_005.jpg GRAPHIC 11238
  Complete submission text file 0001213900-21-052176.txt   573585
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 211316656
SIC: 2834 Pharmaceutical Preparations